senicapoc has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, T; Bulk, E; Dabel, J; Heßling, K; Koch, O; Konken, CP; Maskri, S; Schäfers, M; Schelhaas, S; Schwab, A; Thale, I; Wünsch, B | 1 |
| Brömmel, K; Koch, O; Maskri, S; Schwab, A; Thale, I; Todesca, LM; Wünsch, B | 1 |
| Cil, O; Duan, T; Thiagarajah, JR; Verkman, AS | 1 |
1 review(s) available for senicapoc and Neoplasms
| Article | Year |
|---|---|
Targeting K
Topics: Acetamides; Antineoplastic Agents; Antisickling Agents; Binding Sites; Calcium; Calcium Signaling; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Molecular Dynamics Simulation; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasms; Potassium Channel Blockers; Protein Structure, Secondary; Small-Conductance Calcium-Activated Potassium Channels; Trityl Compounds; Tumor Microenvironment | 2021 |
2 other study(ies) available for senicapoc and Neoplasms
| Article | Year |
|---|---|
Imaging of the calcium activated potassium channel 3.1 (K
Topics: Animals; Fluorine Radioisotopes; Humans; Mice; Neoplasms; Positron-Emission Tomography; Potassium Channels, Calcium-Activated; Radiopharmaceuticals; Structure-Activity Relationship; Tissue Distribution | 2022 |
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
Topics: Acetamides; Afatinib; Animals; Cell Membrane Permeability; Clotrimazole; Colon; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Epithelial Cells; ErbB Receptors; Female; Humans; Intestinal Mucosa; Neoplasms; Oxazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyrimidinones; Pyrroles; Rats; Trityl Compounds | 2019 |